Oncternal Therapeutics Inc Cash Flow Reinvestment Rate
Latest as of March 2008:
0.02x
Oncternal Therapeutics Inc cash flow reinvestment rate. Oncternal Therapeutics Inc (ONCT) has a Cash Flow Reinvestment Rate of 0.02x as of March 2008, reinvesting $697.00K (capex $697.00K ) from operating cash flow of $28.70 Million. Explore Oncternal Therapeutics Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
0.02x
(Capex + Investments) / Operating CF
Total Reinvested
$697.00K
Capex + Investments
Operating Cash Flow
$28.70 Million
USD
Capital Expenditures
$697.00K
USD
Oncternal Therapeutics Inc Cash Flow Reinvestment Rate by Year (None–None)
Oncternal Therapeutics Inc cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Oncternal Therapeutics Inc. For the full cash flow conversion analysis, see ONCT cash flow metrics.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow